Loading
IDP-023 is an experimental allogeneic natural killer cell therapy from Indapta Therapeutics, in phase 2 trials for relapsed or refractory multiple myeloma and relapsed or refractory non-Hodgkin lymphoma.
IDP-023 (g-NK cells) is an allogeneic natural killer (NK) cell therapy from Indapta Therapeutics. Off-the-shelf NK cells from healthy donors, drawn from a subset deficient in the FceR1g protein (g-NK cells); given alone or with tumour-targeting antibodies. Its furthest stage is phase 2, for relapsed or refractory multiple myeloma and relapsed or refractory non-Hodgkin lymphoma. ClinicalTrials.gov registers it in one study linked below. NCT06119685 (phase 1/2, haematologic cancers) RECRUITING. The multiple sclerosis study NCT06677710 is SUSPENDED (non-oncology). Whether it works in people has not been established unless a trial below reports it.
Off-the-shelf NK cells from healthy donors, drawn from a subset deficient in the FceR1g protein (g-NK cells); given alone or with tumour-targeting antibodies.
1.IDP-023 slips into a pocket on its target.
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"IDP-023" OR ABSTRACT:"IDP-023" OR TITLE:"g-NK cells" OR ABSTRACT:"g-NK cells") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about IDP-023, not a curated reading list.
Shares Relapsed or refractory multiple myeloma and the tag pipeline.
Shares Relapsed or refractory multiple myeloma and the tag pipeline.
Shares Relapsed or refractory multiple myeloma and the tag pipeline.
Shares Relapsed or refractory multiple myeloma and the tag pipeline.
Shares Relapsed or refractory multiple myeloma and the tag pipeline.
Shares Relapsed or refractory multiple myeloma and the tag pipeline.
Shares Non-Hodgkin lymphoma (all types) and the tag pipeline.
Shares Relapsed or refractory multiple myeloma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/